Method
Level · gp.fundamentals.debt_to_revenue
Raw value 254.37% · OPTIONAL
· Services-Commercial Physical & Biological Research
RESEARCH SNAPSHOTNRC HEALTH's latest supported as-filed period reports revenue of $35.4M, 4.0% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 254.37% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.74% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 3.92% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 3.98% · CORE
Level · gp.fundamentals.operating_margin
Raw value -9.15% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 20.83% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -36.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -2997.2% from the comparable as-filed period.
Operating income changed -303.9% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
NRC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-027031SEC ↗10-QAug 4, 2026Period Jun 30, 20260001437749-26-025624SEC ↗8-KJul 28, 2026Period Jul 28, 20260001437749-26-024663SEC ↗8-KJun 29, 2026Period Jun 23, 20260001437749-26-021938SEC ↗4Jun 25, 2026Period Jun 23, 20260001008886-26-000189SEC ↗4Jun 25, 2026Period Jun 23, 20260001008886-26-000188SEC ↗4Jun 25, 2026Period Jun 23, 20260001008886-26-000187SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 23, 2026Filed Jun 25, 2026 | Berwick Donald MDirector | Grant Or AwardDirect | 7,697 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating margin changed -1381 basis points from the comparable as-filed period.
Revenue changed +4.0% from the comparable as-filed period.
Selling, general & administrative changed +29.4% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001008886-26-000186